Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension.
[Contributions of the First International Consensus on grade 1 Hypertension with low to moderate cardiovascular risk].
Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial.
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.
Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, Mulatero P, Murad MH, Touyz RM, Vaidya A, Williams TA, Yang J, Young WF, Zennaro MC, Brito JP.
J Clin Endocrinol Metab. 2025 Aug 7;110(9):2453-2495. doi: 10.1210/clinem/dgaf284.
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.
Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.
Exercise-based rehabilitation programmes for pulmonary hypertension.
Morris NR, Kermeen FD, Jones AW, Lee JY, Holland AE.
Cochrane Database Syst Rev. 2023 Mar 22;3(3):CD011285. doi: 10.1002/14651858.CD011285.pub3.
Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension.
Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H, Zhu L, Hu F, Li X, Meng S, Yan R, Zhao S, Onwuka JU, Yang B, Sun D, Zhao Y.
J Am Heart Assoc. 2020 Oct 20;9(19):e016804. doi: 10.1161/JAHA.120.016804. Epub 2020 Sep 25.
Beta-blockers for hypertension.
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH.
Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003. doi: 10.1002/14651858.CD002003.pub5.
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Sundström J, Lind L, Nowrouzi S, Hagström E, Held C, Lytsy P, Neal B, Marttala K, Östlund O.
JAMA. 2023 Apr 11;329(14):1160-1169. doi: 10.1001/jama.2023.3322.
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A.
Curr Probl Cardiol. 2017 Jul;42(7):198-225. doi: 10.1016/j.cpcardiol.2017.03.001. Epub 2017 Mar 8.
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.
Hofmeyr GJ, Lawrie TA, Atallah ÁN, Torloni MR.
Cochrane Database Syst Rev. 2018 Oct 1;10(10):CD001059. doi: 10.1002/14651858.CD001059.pub5.
Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial.
Jiang Y, Qu H, Guo H, Guo M, Liang J, Niu Y, Chen L, Wang X, Li Y, Jiang H, Ma J, Wang Z, Luan S, Lu C, Shi D.
Phytomedicine. 2025 Nov 25;148:157315. doi: 10.1016/j.phymed.2025.157315. Epub 2025 Sep 23.
Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial.
Qu H, Shen AL, Yang K, Huang MY, Li HZ, Yang WW, Fan SY, Tan L, Wang J, Peng YX, Chu JF, Peng J, Fu CG, Long LZ, Chen KJ.
Pharmacol Res. 2024 Feb;200:107052. doi: 10.1016/j.phrs.2023.107052. Epub 2024 Jan 4.
